Medifast earnings were $248.0k for the trailing 12 months ending Sep 30, 2025, with -97% growth year over year. The latest MED earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$2.3M, down 191.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MED reported annual earnings of $2.1M, with -97.9% growth.
MED past earnings growth
How has MED's earnings growth performed historically?
On MED's earnings call on Invalid Date, Medifast (NYSE: MED) reported Q3 2025 earnings per share (EPS) of -$0.21, up 310% year over year. Total MED earnings for the quarter were -$2.26 million. In the same quarter last year, Medifast's earnings per share (EPS) was $0.10.
As of the last Medifast earnings report, Medifast is currently profitable. Medifast's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $248.00 thousand, a 96.61% decrease year over year.
What was MED's earnings growth in the past year?
As of Medifast's earnings date in Invalid Date, Medifast's earnings has grown -96.97% year over year. This is 113.48 percentage points lower than the US Personal Services industry earnings growth rate of 16.51%. MED earnings in the past year totalled $248.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.